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Abstract 
The examination of the palladium catalysed arylation reactions of mono-iodo derivatives of the phenyl 
and benzyl esters of benzoic acid, phenylacetic acid and dehydrocinnamic acid has resulted in the 
formation of benzo[c]chromen-6-ones, unexpected cinnamate and succinate products and diphenyl 
dimers. Many of these products can be rationalized as arising from novel cyclic ArPd(II)-enolate 
intermediates, formed by intramolecular C-H activation by ArPd(II). 
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Abstract: The examination of the palladium catalysed arylation reactions of mono-iodo derivatives of 
the phenyl and benzyl esters of benzoic acid, phenylacetic acid and dehydrocinnamic acid has resulted 
in the formation of benzo[c]chromen-6-ones, unexpected cinnamate and succinate products and 
diphenyl dimers. Many of these products can be rationalized as arising from novel cyclic ArPd(II)-
enolate intermediates, formed by intramolecular C-H activation by ArPd(II). 
 
As part of a project concerned with the synthesis of lactones of the type C we have explored the 
palladium catalysed arylation reactions of mono-iodo di-aryl esters A and B as shown in Scheme 1.  
The formation of benzo[c]chromen-6-ones C (m = n = 0) have been readily achieved from palladium 
catalysed cyclization of the corresponding mono-iodophenyl benzoate derivative using this strategy.1,2 
In the successful cases reported the iodo-substituent is normally attached to the more electron deficient 
benzoate ring as in the case of A (m = n = 0).  The formation of larger lactone rings have not been 
reported, however the palladium catalysed arylation reaction has been used to form 7-membered 
carbocyclic and azepine rings.2c,3 We report here our results from the examination of the palladium 
catalysed arylation reactions of mono-iodo derivatives of the phenyl and benzyl esters of benzoic acid, 
















A, X = I, Y = H 





Treatment of the iodo-substituted phenyl benzoate derivatives 1a-c with 26 mol % (Ph3P)2PdCl2 in the 
presence of anhydrous sodium acetate (3 molar equiv.) in DMA with heating in a sealed tube at 125 oC 
for 3 h gave the benzo[c]chromen-6-ones 2a-c in good yields (Scheme 2).  In the case of 1c, a small 

















a; R1 = OMe, R2 = OMe, R3 = H
b; R1 = OMe, R2 = OMe, R3 = OMe






















125 oC, 3 h
I
   
When the 2-iodophenyl phenyl acetates 4a-c were treated under identical conditions to 1a-c only 
products arising from hydrolysis of the ester group of 4a-c were obtained, even though the NaOAc and 










125 oC, 3 h
4
a; R1 = OMe, R2 = OMe, X = I, Y = H
b; R1 = OMe, R2 = H, X = H, Y = I






Treatment of the phenyl dihydrocinnamate 5 under these conditions resulted in formation of its 
cinnamate ester derivative 6 in 59% yield (Scheme 4). A possible mechanism is shown in Scheme 5. 
4 
This mechanism involves oxidative addition of the aryl iodide to Pd(0), to give the Pd(II)-intermediate 
D from which base (NaOAc) assisted cyclometallation occurs, via C-H functionalization, to give the 
palladacycle E.  Intermediate E can undergo selective protonation to give the Pd(II)-enolate species F 
which upon -elimination would give the cinnamate 6 and Pd(II)H. The latter species upon reaction 
with acetate ion would generate Pd(0) and acetic acid.  The functionalization of sp3C-H and sp2C-H 
bonds by Pd(II), as in the case of the conversion of intermediate D to E, have been well documented4 
and palladium(IV) species have been suggested as intermediates in some of these reactions.4b,h,k,p,q 
Indeed oxidative addition of intermediate D could provide the palladium(IV) intermediate G which 


































































The palladium catalysed reactions of the 2-iodobenzyl 3,4-dimethoxyphenyl acetates 7a,b gave a 
mixture of two products which consisted of the benzo[c]chromen-6-ones 8a and 8b, respectively and 
the biphenyls 9a and 9b, respectively (Scheme 6).  These compounds were readily separated by column 
chromatography.  The 3,4-dimethoxybenzyl 2-iodophenyl acetates 10a,b gave different products.  
Iodide 10a gave a separable mixture of the succinate 11 (as a 1.8 : 1 mixture of diastereomers) and the 
biphenyl 12, while 10b gave the benzo[c]chromen-6-one 8b (Scheme 7). These unexpected products 
can be rationalized as arising through similar palladium intermediates to those suggested in Scheme 5.  
In Scheme 8, the Pd(II)-palladacycle intermediate I is formed from 7a,b in an analogous fashion to E 
in Scheme 5.  Reductive elimination of I would provide the benzo[c]chromen-6-ones 8a or 8b.  
Alternatively, dimerization of intermediate H would give the diphenyls 9a or 9b. 
In Scheme 9, the Ar-Pd(II)I intermediate J could undergo deprotonation by NaOAc, perhaps assisted 
by coordination between the Pd(II) and the ester carbonyl, to give the Pd(II)-palladacycle K which 
could undergo selective protonation by HOAc to give the O-Pd(II)-enolate L.  The latter would be 
6 
expected to be in equilibrium with the C-Pd(II)-enolate M5 which could give rise to the same cyclic 
Pd(II)-enolate intermediate I suggested in Scheme 8 and then product 8b via reductive elimination.  
Alternatively, dimerization of intermediate M could provide the succinate 11.  The proposed Pd(II)-
palladacycle K is similar to that proposed as an intermediate in the Pd-catalysed intramolecular 
coupling ortho-bromophenylmethyl ketones to give benzofurans under basic conditions.5  However no 
benzofuran products could be isolated from our reactons.  We assume that because our reactions 
generate an equivalent of HOAc, from the transformation of intermediate J to K, that protonation of K 
to give L is more rapid than benzofuran formation.6 
In conclusion, the examination of the palladium catalysed arylation reactions of mono-iodo derivatives 
of the phenyl and benzyl esters of benzoic acid, phenylacetic acid and dehydrocinnamic acid has 
resulted in the formation of benzo[c]chromen-6-ones 2a-c and 8a,b, the unexpected cinnamate 6 and 
the succinate 11 and diphenyl dimers (9a,b and 12). Many of these products can be rationalized as 
arising from novel cyclic ArPd(II)-enolate intermediates (E and I). While the formation of ArPd(II)-
enolate intermediates is well documented, these are normally generated from the intermolecular 
reaction of an in situ generated or preformed enolate anion, using a stronger base than NaOAc as in this 
study, and a ArPd(II)X species7 and not by intramolecular C-H activation by ArPd(II) as we have 









125 oC, 3 h
7a, R = H





























125 oC, 3 h
10a, R = H



























































































All NMR spectra were measured in CDCl3 solution at 300 MHz (
1H NMR) or 75 MHz (13C NMR) 
unless otherwise indicated. NMR assignments are based on COSY, DEPT, and HSQC experiments and 
sometimes HMBC and NOESY experiments.  DCM refers to CH2Cl2 and PS refers to petroleum spirit 
(b.p. 40-60 oC) 
 
General Methods for Ester Formation 
3,4-Dimethoxyphenyl 2-iodo-4,5-dimethoxybenzoate 1a 
A solution of 2-iodo-4,5-dimethoxybenzoic acid (613 mg, 1.99 mmol), 3,4-dimethoxyphenol (368 mg, 
2.39 mmol) and DCC (493 mg, 2.39 mmol), DMAP (73 mg, 0.59 mmol) in DCM (20 mL) was stirred 
at rt for 18 h under N2, diluted with DCM (20 mL), filtered and the filtrate washed with water (20 mL) 
and saturated NaHCO3 solution (20 mL). The organic phase was dried (MgSO4), filtered, evaporated 
and the residue chromatographed, using EtOAc:PS (1:1) as the mobile phase, to yield the title 
compound as a white solid (671 mg, 76 %). M.p. 146-148 oC 1H NMR: δ 7.64 (s, 1H, Ar-H-6), 7.45 (s, 
1H, Ar-H-3), 6.89 (d, 1H, J = 8.0 Hz, Ar-H-5’), 6.79 (d, 1H, J = 2.2 Hz, Ar-H-2’), 6.78 (dd, 1H, J = 
8.0, 2.2 Hz, Ar-H-6’), 3.95 (s, 3H, OCH3-4), 3.94 (s, 3H, OCH3-5), 3.89 (s, 3H, OCH3-4’), 3.88 (s, 3H, 
OCH3-3’).   
13C NMR: δ 164.0 (C=O), 152.2 (Ar-C-OCH3-4), 149.3 (Ar-C-OCH3-3’), 148.6 (Ar-C-
OCH3-5), 146.8 (Ar-C-OCH3-4’), 144.2 (Ar-C-1’), 124.8 (Ar-C-1), 123.9 (Ar-C-H-3), 114.1 (Ar-C-H-
6), 112.9 (Ar-C-H-6’), 111.1 (Ar-C-H-5’), 105.8 (Ar-C-H-2’), 85.5 (Ar-C-2), 56.2 (Ar-OCH3-4), 56.1 
(Ar-OCH3-4’), 56.0 (Ar-OCH3-5), 55.9 (Ar-OCH3-3’). MS (EI+): m/z 444 (M
+, 8 %), 291 (100 %), 
HRMS (EI+): Calcd for C17H17IO6 = 444.0069 (M
+), found 444.0053. 
 
3,4-Dimethoxyphenyl 2-iodo-3,4,5-trimethoxybenzoate 1b 
The title compound was prepared in 91 % yield (white solid, 483 mg) from 2-iodo-3,4,5-
trimethoxybenzoic acid (379 mg, 1.12 mmol) and 3,4-dimethoxyphenol (207 mg, 1.34 mmol) in the 
presence of DCC (277 mg, 1.34 mmol), DMAP (34 mg, 0.28 mmol) and DCM (10 mL) according to 
the general esterification method. M.p. 98-100 oC. 1H NMR: δ 7.39 (s, 1H, Ar-H-6), 6.90 (dd, 1H, J = 
7.3, 2.4 Hz Ar-H-6’), 6.84 (d, 1H, J = 2.4 Hz Ar-H-2’), 6.82 (d, 1H, J = 7.3 Hz Ar-H-5’), 3.95 (s, 3H, 
OCH3-5), 3.93 (s, 3H, OCH3-4), 3.91 (s, 3H, OCH3-3), 3.90 (s, 3H, OCH3-3’), 3.89 (s, 3H, OCH3-4’).  
13C NMR: δ 165.1 (C=O), 153.9 (Ar-C-OCH3-3), 153.4 (Ar-C-OCH3-4), 149.4 (Ar-C-OCH3-4’), 147.0 
(Ar-C-OCH3-3’), 145.3 (Ar-C-OCH3-5), 144.2 (Ar-C-1’), 129.9 (Ar-C-1), 112.8 (Ar-C-H-5’), 111.1 
(Ar-C-H-6), 110.9 (Ar-C-H-6’), 105.6 (Ar-C-H-2’), 84.5 (Ar-C-2), 61.0 (OCH3-5), 60.8 (OCH3-3’), 
10 
56.3 (OCH3-4), 56.1 (OCH3-3), 55.9 (OCH3-4’). MS: m/z (EI
+) 474 (M+, 6 %), 321 (100 %) HRMS 
(EI+): Calcd for C18H19IO7 = 474.0175 (M
+), found 474.0152. 
 
3,4-Dimethoxyphenyl 2-iodobenzoate 1c 
The title compound was prepared in 93 % yield (white solid, 1.15 g) from 2-iodobenzoic acid (800 mg, 
3.22 mmol) and 3,4-dimethoxyphenol (547 mg, 3.54 mmol) in the presence of DCC (732 mg, 3.54 
mmol), DMAP (130 mg, 1.06 mmol) and DCM (15 mL) according to the general esterification method. 
M.p. 74-76 oC. 1H NMR: δ 8.06 (d, 1H, J = 8.0 Hz, Ar-H-3), 8.02 (dd, 1H, J = 8.0, 1.5 Hz, Ar-H-6), 
7.47 (t, 1H, J = 8.0 Hz, Ar-H-5), 7.21 (dt, 1H, J = 8.0, 1.5 Hz, Ar-H-4), 6.99 (d, 1H, J = 8.0 Hz, Ar-H-
5’), 6.81 (dd, 1H, J = 8.0, 2.5 Hz, Ar-H-6’), 6.80 (d, 1H, J = 2.5 Hz, Ar-H-2’), 3.89 (s, 3H, OCH3-3’), 
3.88 (s, 3H, OCH3-4’). 
13C NMR: δ 165.0 (C=O), 149.3 (Ar-C-OCH3-4), 147.0 (Ar-C-OCH3-3), 144.2 
(Ar-C-1’), 141.5 (Ar-C-H-3), 134.1 (Ar-C-1), 133.1 (Ar-C-H-4), 131.4 (Ar-C-H-6), 127.9 (Ar-C-H-5), 
112.8 (Ar-C-H-6’), 111.1 (Ar-C-H-5’), 105.6 (Ar-C-H-2’), 94.5 (Ar-C-2), 56.1 (Ar-OCH3-4’), 55.9 
(Ar-OCH3-3’). MS: m/z (EI
+) 384 (M+, 6 %), 125 (100 %), HRMS (EI+): Calcd for C15H13IO4 = 
383.9858 (M+), found 383.9862. 
 
3,4-Dimethoxyphenyl 2-iodo-4,5-dimethoxyphenylacetate 4a 
The title compound was prepared in 76 % yield (sticky white solid, 740 mg) from 2-iodo-4,5-
dimethoxyphenylacetic acid (686 mg, 2.12 mmol) and 3,4-dimethoxyphenol (361 mg, 2.34 mmol) in 
the presence of DCC (483 mg, 2.34 mmol), DMAP (73 mg, 0.59 mmol) and DCM (10 mL) according 
to esterification method. M.p. 76-78 oC.  1H NMR: δ 7.27 (s, 1H, Ar-H-3), 6.90 (s, 1H, Ar-H-6), 6.82 
(s, 1H, Ar-H-5’), 6.69 (s, 1H, Ar-H-2’), 6.68 (s, 1H, Ar-H-6’), 3.95 (s, 2H, Ar-CH2), 3.876 (s, 3H, 
OCH3-3), 3.870 (s, 3H, OCH3-5), 3.86 (s, 3H, OCH3-4’), 3.85 (s, 3H, OCH3-4). 
13C NMR: δ 169.5 
(C=O), 149.4 (Ar-C-OCH3-4), 149.3 (Ar-C-OCH3-3’), 148.8 (Ar-C-OCH3-3), 146.9 (Ar-C-OCH3-4’), 
144.3 (Ar-C-1’), 129.5 (Ar-C-1), 121.6 (Ar-C-H-3), 113.4 (Ar-C-H-6), 112.7 (Ar-C-H-6’), 111.1 (Ar-
C-H-5’), 105.6 (Ar-C-H-2’), 88.9 (Ar-C-2), 56.1 (2 x OCH3-3, 5), 55.9 (2 x OCH3-4, 4’), 45.7 (Ar-
CH2). MS: m/z (EI
+) 458 (M+, 3 %), 149 (100 %), HRMS (EI+): Calcd for C18H19IO6 = 458.0226 (M
+) 
, found 458.0233. 
 
2-Iodophenyl 3,4-dimethoxyphenylacetate 4b 
The title compound was prepared in 91 % yield (clear oil, 1.65 g) from 3,4-dimethoxyphenylacetic acid 
(980 mg, 4.99 mmol) and 2-iodophenol (1.0 g, 4.54 mmol) in the presence of DCC (1.03 mg, 4.99 
11 
mmol), DMAP (166 mg, 1.36 mmol) and DCM (20 mL) according to esterification method. M.p. 52-54 
oC. 1H NMR: δ 7.79 (d, 1H, J = 8.0 Hz, Ar-H-3’), 7.32 (t, 1H, J = 7.5 Hz, Ar-H-5’), 7.05 (d, 1H, J = 
7.5 Hz, Ar-H-6’), 6.96 (bs, 1H, Ar-H-2), 6.96-6.93 (m, 1H, Ar-H-6), 6.94 (t, 1H, J = 8.0 Hz, Ar-H-4’), 
6.85 (d, 1H, J = 8.0 Hz, Ar-H-5), 3.89 (s, 3H, OCH3-3), 3.869 (s, 3H, OCH3-4), 3.864 (s, 2H, Ar-CH2). 
13C NMR: δ 169.2 (C=O), 151.0 (Ar-C-1’), 148.8 (Ar-C-OCH3-4), 148.3 (Ar-C-OCH3-3), 139.3 (Ar-C-
H-3’), 129.2 (Ar-C-H-5’), 127.5 (Ar-C-H-4’), 125.3 (Ar-C-1), 122.8 (Ar-C-H-6’), 121.7 (Ar-C-H-6), 
112.7 (Ar-C-H-2), 111.1 (Ar-C-H-5), 90.1 (Ar-C-H-2’), 55.8 (Ar-OCH3-4), 55.7 (Ar-OCH3-3), 40.8 
(Ar-CH2). MS: m/z (EI
+) 398 (M+, 46 %), 151 (100 %), HRMS (EI+): Calcd for C16H15IO4 = 398.0015 
(M+), found 398.0012. 
 
3,4-Dimethoxyphenyl 2-iodophenylacetate 4c 
The title compound was prepared in 92 % yield (clear oil, 1.41 g) from 2-iodophenylacetic acid (1.00 g, 
3.81 mmol) and 3,4-dimethoxyphenol (647 mg, 4.19 mmol) in the presence of DCC (866 mg, 4.19 
mmol), DMAP (140 mg, 1.14 mmol) and DCM (20 mL) according to esterification method. M.p. 90-92 
oC. 1H NMR: δ 7.87 (d, 1H, J = 7.5 Hz, Ar-H-3), 7.37 (d, 1H, J = 7.5 Hz, Ar-H-6), 7.33 (t, 1H, J = 7.5 
Hz, Ar-H-5), 6.98 (t, 1H, J = 7.5 Hz, Ar-H-4), 6.81 (d, 1H, J = 8.0 Hz, Ar-H-5’), 6.69 (d, 1H, J = 1.5 
Hz, Ar-H-2’), 6.68 (dd, 1H, J = 8.0, 1.5 Hz, Ar-H-6’), 4.01 (s, 2H, Ar-CH2), 3.84 (s, 3H, OCH3-3’), 
3.83 (s, 3H, OCH3-4’). 
13C NMR: δ 169.1 (C=O), 149.1 (Ar-C-OCH3-3’), 146.7 (Ar-C-OCH3-4’), 
144.2 (Ar-C-1’), 139.4 (Ar-C-H-3), 137.2 (Ar-C-1), 130.7 (Ar-C-H-6), 129.0 (Ar-C-H-4), 128.4 (Ar-C-
H-5), 112.6 (Ar-C-H-6’), 111.0 (Ar-C-H-5’), 105.5 (Ar-C-H-2’), 100.8 (Ar-C-2), 56.0 (Ar-OCH3-3’), 
55.8 (Ar-OCH3-4’), 46.1 (Ar-CH2).   MS: m/z (EI
+) 398 (M+, 5 %), 154 (100 %), HRMS (EI+): Calcd 
for C16H15IO4 = 398.0015 (M
+), found 398.0002. 
 
3,4-Dimethoxyphenyl 3-(2-iodo-4,5-dimethoxyphenyl)propionate 5 
The title compound was prepared in 81 % yield (cream solid, 669 mg) from 3-(2-iodo-4,5-
dimethoxyphenyl)propanoic acid  (566 mg, 1.68 mmol) and 3,4-dimethoxyphenol (286 mg, 1.85 
mmol) in the presence of DCC (382 mg, 1.85 mmol), DMAP (51 mg, 0.42 mmol) and DCM (13 mL) 
according to the general esterification method. M.p. 100-102 oC. 1H NMR: δ 7.22 (s, 1H, Ar-H-3), 6.83 
(s, 1H, Ar-H-6), 6.81 (d, 1H, J = 8.7 Hz Ar-H-5’), 6.58 (dd, 1H, J = 8.7, 2.5 Hz Ar-H-6’), 6.55 (d, 1H, 
J = 2.5 Hz Ar-H-2’), 3.83 (s, 3H, OCH3), 3.84 (s, 3H, OCH3), 3.83 (s, 3H, OCH3), 3.82 (s, 3H, OCH3), 
3.09 (t, 2H, J = 7.3, Ar-CH2), 2.83 (t, 2H, J = 7.3, Ar-CH2-CH2). 
13C NMR: δ 171.3 (C=O), 149.3 (2 x 
Ar-C-OCH3-4, 4’), 148.1 (Ar-C-OCH3-5), 146.7 (Ar-C-OCH3-3’), 144.1 (Ar-C-1’), 135.0 (Ar-C-1), 
12 
121.7 (Ar-C-H-3), 112.7 (Ar-C-H-6), 112.6 (Ar-C-H-6’), 111.0 (Ar-C-H-5’), 105.5 (Ar-C-H-2’), 87.7 
(Ar-C-2), 56.1 (2 x Ar-OCH3-3’, 5), 55.8 (2 x Ar-OCH3-4, 4’), 35.4 (Ar-CH2), 34.6 (Ar-CH2-CH2). 




2-Iodobenzyl (3,4-dimethoxyphenyl)acetate 7a  
The title compound was prepared in 81 % yield (clear oil, 1.42 g) from 3,4-dimethoxyphenylacetic acid 
(922 mg, 4.70 mmol) and 2-iodobenzyl alcohol (1.00 g, 4.27 mmol) in the presence of DCC (969 mg, 
4.70 mmol), DMAP (156 mg, 1.28 mmol) and DCM (20 mL) according to the general esterification 
method. M.p. 52-54 oC  1H NMR: δ 7.82 (d, 1H, J = 7.5 Hz, Ar-H-3’), 7.30 (t, 1H, J = 7.5 Hz, Ar-H-
5’), 7.28 (d, 1H, J = 7.5 Hz, Ar-H-6’), 6.99 (dt, 1H, J = 7.5, 2.0 Hz, Ar-H-4’), 6.84 (d, 1H, J = 8.5 Hz, 
Ar-H-6), 6.83 (bs, 1H, Ar-H-2), 6.80 (d, 1H, J = 8.5 Hz, Ar-H-5), 5.13 (s, 2H, Ar-CH2-O), 3.85 (s, 3H, 
OCH3-4), 3.84 (s, 3H, OCH3-3), 3.63 (s, 2H, Ar-CH2-CO). 
13C NMR: δ 171.1 (C=O), 148.8 (Ar-C-
OCH3-3), 148.0 (Ar-C-OCH3-4), 139.3 (Ar-C-H-3’), 138.1 (Ar-C-1’), 129.7 (Ar-C-H-4’), 129.3 (Ar-C-
H-6’), 128.1 (Ar-C-H-5’), 126.0 (Ar-C-1), 121.4 (Ar-C-H-6), 112.3 (Ar-C-H-2), 111.1 (Ar-C-H-5), 
98.1 (Ar-C-2’), 70.1 (Ar-CH2-O), 55.78 (Ar-OCH3-4), 55.73 (Ar-OCH3-3), 40.4 (Ar-CH2-CO). MS: 




2-Iodo-4,5-dimethoxybenzyl 3,4-dimethoxyphenylacetate 7b 
The title compound was prepared in 70 % yield (92 % brsm, orange solid, 720 mg) from 3,4-
dimethoxyphenylacetic acid (474 mg, 2.41 mmol) and 2-iodo-4,5-dimethoxybenzyl alcohol (645 mg, 
2.19 mmol) in the presence of DCC (498 mg, 2.41 mmol), DMAP (80 mg, 0.69 mmol) and DCM (10 
mL) according to the general esterification method. (2-iodo-4,5-dimethoxybenzyl alcohol (159 mg) 
was recovered from the reaction.) M.p. 88-90 oC. 1H NMR: δ 7.23 (s, 1H, Ar-H-3’), 6.84 (d, 1H, J = 
7.0 Hz, Ar-H-5), 6.83 – 6.81 (m, 1H, Ar-H-6), 6.81 (d, 1H, J = 2.4 Hz, Ar-H-2), 6.79 (s, 1H, Ar-H-6’), 
5.09 (s, 2H, Ar-CH2-O), 3.86 (s, 6H, OCH3-4’, 5’), 3.85 (s, 3H, OCH3-3), 3.76 (s, 3H, OCH3-4), 3.62 
(s, 1H, Ar-CH2-CO). 
13C NMR: δ 171.3 (C=O), 149.3 (Ar-C-OCH3-4), 149.2 (Ar-C-OCH3-4’), 148.8 
(Ar-C-OCH3-5’), 148.1 (Ar-C-OCH3-3), 130.6 (Ar-C-1’), 126.2 (Ar-C-1), 121.6 (Ar-C-H-3’), 121.4 
(Ar-C-H-5), 112.6 (Ar-C-H-6’), 112.4 (Ar-C-H-6), 111.1 (Ar-C-H-2), 86.9 (Ar-C-2’), 70.2 (Ar-CH2-
O), 56.1 (Ar-OCH3-3), 55.85 (2 x Ar-OCH3-4, 4’), 55.83 (Ar-OCH3-5’), 40.8 (Ar-CH2-CO). MS: m/z 
13 




3,4-Dimethoxybenzyl (2-iodophenyl)acetate 10a 
The title compound was prepared in 91 % yield (clear oil, 1.42 g) from 2-iodophenylacetic acid 261 
(1.0 g, 3.82 mmol) and 3,4-dimethoxybenzyl alcohol 231 (706 mg, 4.19 mmol) in the presence of DCC 
(866 mg, 4.19 mmol), DMAP (140 mg, 1.14 mmol) and DCM (20 mL) according to esterification 
method. 1H NMR: δ 7.83 (d, 1H, J = 8.0 Hz, Ar-H-3), 7.29 (d, 1H, J = 8.0 Hz, Ar-H-6), 7.28 (t, 1H, J = 
8.0 Hz, Ar-H-5), 6.94 (t, 1H, J = 8.0 Hz, Ar-H-4), 6.90 (d, 1H, J = 8.0 Hz, Ar-H-6’), 6.85 (bs, 1H, Ar-
H-2’), 6.81 (d, 1H, J = 8.0 Hz, Ar-H-5’), 5.10 (s, 2H, Ar-CH2-O), 3.86 (s, 3H, OCH3-3’), 3.84 (s, 3H, 
OCH3-4’), 3.82 (s, 2H, Ar-CH2-CO). 
13C NMR: δ 170.2 (C=O), 148.9 (Ar-C-OCH3-4’), 148.8 (Ar-C-
OCH3-3’), 139.3 (Ar-C-H-3), 137.6 (Ar-C-1), 130.5 (Ar-C-H-5), 128.7 (Ar-C-H-4), 128.3 (Ar-C-H-6), 
128.1 (Ar-C-1’), 121.0 (Ar-C-H-6’), 111.5 (Ar-C-H-2’), 110.8 (Ar-C-H-5’), 100.9 (Ar-C-2), 66.7 (Ar-
CH2-O), 55.79 (Ar-OCH3-4’), 55.78 (Ar-OCH3-3’), 46.2 (Ar-CH2-CO). MS: m/z (EI
+) 412 (M+, 48 %), 
151 (100 %), HRMS (EI+): Calcd for C17H17IO4 = 412.0171, found 412.0158. 
 
 
3,4-Dimethoxybenzyl 2-iodo-4,5-dimethoxyphenylacetate 10b 
The title compound was prepared in 77 % yield (white solid, 452 mg) from 2-iodo-3,4-
dimethoxyphenylacetic acid 254 (400 mg, 1.24 mmol) and 3,4-dimethoxybenzyl alcohol 231 (229 mg, 
1.36 mmol) in the presence of DCC (282 mg, 1.36 mmol), DMAP (45 mg, 0.37 mmol) and DCM (10 
mL) according to esterification method. M.p. 96-98 oC. 1H NMR: δ 7.23 (s, 1H, Ar-H-3), 6.91 (dd, 1H, 
J = 8.0, 2.0 Hz, Ar-H-6’), 6.88 (d, 1H, J = 2.0 Hz, Ar-H-2’), 6.83 (d, 1H, J = 8.0 Hz, Ar-H-5’), 6.78 (s, 
1H, Ar-H-6), 5.11 (s, 2H, Ar-CH2-O), 3.87 (s, 3H, OCH3-3’), 3.86 (s, 3H, OCH3-4’), 3.84 (s, 3H, 
OCH3-5), 3.81 (s, 3H, OCH3-4), 3.76 (s, 2H, Ar-CH2-CO). 
13C NMR: δ 170.6 (C=O), 149.0 (Ar-C-
OCH3-4), 148.9 (2 x Ar-C-OCH3-4’, 5’), 148.6 (Ar-C-OCH3-5), 129.9 (Ar-C-1), 128.2 (Ar-C-1’), 
121.5 (Ar-C-H-3), 121.1 (Ar-C-H-6’), 113.2 (Ar-C-H-6), 111.6 (Ar-C-H-5’), 110.8 (Ar-C-H-2’), 88.8 
(Ar-C-2), 66.7 (Ar-CH2-O), 56.1 (Ar-OCH3-5’), 55.87 (2 x Ar-OCH3-4, 4’), 55.86 (Ar-OCH3-3’), 45.7 
(Ar-CH2-CO). MS: m/z (EI
+) 472 (M+, 9 %), 151 (100 %) HRMS (ES+): Calcd for C19H22IO6 = 
473.0461 (M+H+), found 473.0443. 
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General Method For Palladium-Mediated Arylation 
2,3,8,9-Tetramethoxy-6H-benzo[c]chromen-6-one 2a 
Compound 1a (100 mg, 0.22 mmol), (Ph3P)2PdCl2 (41 mg, 0.058 mmol), anhydrous NaOAc (55 mg, 
0.67 mmol) and DMA (25 mL) were combined in an ACE® pressure tube. The solution was degassed 
for 20 min with Ar, the vessel sealed and heated at 120 0C for 3 h. The tube was cooled to RT and the 
solid residue removed by filtration. The filtrate was diluted with 20 mL of 10 % HCl solution and 
extracted with EtOAc (2 x 20 mL). The combined extracts were washed with H2O (4 x 20 mL), dried 
(MgSO4), filtered, evaporated and the title compound was isolated as a white film (57.2 mg, 80 %) by 
flash silica gel chromatography using DCM:PS:EtOAc (2:2:1) as the eluent. M.p. 217-219 oC  1H 
NMR: δ 7.69 (s, 1H, Ar-H-7), 7.24 (s, 1H, Ar-H-10), 7.22 (s, 1H, Ar-H-1), 6.83 (s, 1H, Ar-H-4), 4.11 
(s, 3H, OCH3-8), 4.02 (s, 3H, OCH3-2), 3.99 (s, 3H, OCH3-9), 3.94 (s, 3H, OCH3-3). 
13C NMR: δ 
161.4 (C=O), 155.1 (Ar-C-OCH3-8), 150.9 (Ar-C-OCH3-3), 149.3 (Ar-C-OCH3-9), 146.3 (Ar-C-4a), 
146.0 (Ar-C-OCH3-2), 130.3 (Ar-C-7a), 113.3 (Ar-C-10a), 110.5 (Ar-C-H-7), 110.0 (Ar-C-1a), 103.8 
(Ar-C-H-10), 102.0 (Ar-C-H-1), 100.8 (Ar-C-H-4), 56.6 (Ar-OCH3-2), 56.3 (Ar-OCH3-8), 56.2 (Ar-
OCH3-9), 56.1 (Ar-OCH3-3). MS: m/z (EI
+) 316 (M+, 100 %) HRMS (CI+): Calcd for C17H17O6 = 




The title compound was prepared in 85 % yield (white solid, 63 mg) from 1b (100 mg, 0.21 mmol), in 
the presence of (Ph3P)2PdCl2 (39 mg, 0.055 mmol), NaOAc (52 mg, 0.63 mmol) and DMA (25 mL) 
according to the general arylation method described above. M.p. 148-150 oC. 1H NMR: δ 8.39 (s, 1H, 
Ar-H-7), 7.72 (s, 1H, Ar-H-1), 6.86 (s, 1H, Ar-H-4), 4.05 (s, 3H, OCH3-8), 4.00 (s, 3H, OCH3-9), 3.99 
(s, 3H, OCH3-10), 3.98 (s, 3H, OCH3-3), 3.94 (s, 3H, OCH3-2).  
13C NMR: δ 161.3 (C=O), 152.8 (Ar-
C-OCH3-10), 150.1 (Ar-C-OCH3-9), 149.9 (Ar-C-OCH3-2), 148.9 (Ar-C-OCH3-3), 145.7 (Ar-C-
OCH3-8), 145.4 (Ar-C-4a), 123.1 (Ar-C-7a), 116.2 (Ar-C-10a), 109.4 (Ar-C-1a), 108.1 (Ar-C-H-7), 
107.9 (Ar-C-H-1), 100.3 (Ar-C-H-4), 61.1 (Ar-OCH3-8), 60.6 (Ar-OCH3-3), 56.2 (Ar-OCH3-9), 56.1 
(Ar-OCH3-10), 56.0 (Ar-OCH3-2). MS: m/z (CI
+) 347 (M+H+, 100 %) HRMS (CI+): Calcd for 
C18H19O7 = 347.1131 (M+H




2,3-Dimethoxy-6H-benzo[c]chromen-6-one 2c and 1,2-Dimethoxy-6H-benzo[c]chromen-6-one 3 
Compound 2c was prepared in 71 % yield (white solid, 47.3 mg) from 1c (100 mg, 0.26 mmol), in the 
presence of (Ph3P)2PdCl2 (39 mg, 0.067 mmol), NaOAc (64 mg, 0.78 mmol) and DMA (25 mL) 
according to the general arylation method described above. Regioisomer 3 was also isolated from the 
reaction as a white solid (9.2 mg, 8 %). NMR data was consistent with the literature for 2c and 3.8  
 
3,4-Dimethoxyphenyl (2E)-3-(3,4-dimethoxyphenyl)acrylate 6 
The title compound was prepared in 59 % yield (yellow film, 43 mg) from 5 (100 mg, 0.20 mmol), in 
the presence of (Ph3P)2PdCl2 (37 mg, 0.053 mmol), NaOAc (51 mg, 0.61 mmol) and DMA (25 mL) 
according to the general arylation method described above. While this is a known compound NMR data 
was not reported.9  1H NMR: δ 7.80 (d, 1H, J = 15.9 Hz, Ar-CH=CH), 7.16 (dd, 1H, J = 8.1, 1.5 Hz, 
Ar-H-6), 7.10 (d, 1H, J = 1.5 Hz, Ar-H-2), 6.89 (d, 1H, J = 8.1 Hz, Ar-H-5), 6.86 (d, 1H, J = 9.3 Hz, 
Ar-H-5’), 6.72 (d, 1H, J = 2.7 Hz, Ar-H-2’), 6.71 (dd, 1H, J = 9.3, 2.7 Hz, Ar-H-6’), 6.48 (d, 1H, J = 
15.9 Hz, Ar-CH=CH), 3.92 (s, 6H, 2 x OCH3-3, 4), 3.88 (s, 3H, OCH3-3’), 3.86 (s, 3H, OCH3-4’). 
13C NMR: δ 166.0 (C=O), 151.4 (Ar-C-OCH3-3), 149.3 (Ar-C-OCH3-4), 149.2 (Ar-C-OCH3-4’), 146.7 
(Ar-C-OCH3-3’), 146.4 (Ar-CH=CH), 144.4 (Ar-C-1’), 127.1 (Ar-C-CH=CH), 122.9 (Ar-C-H-6), 
114.7 (Ar-CH=CH), 112.9 (Ar-C-H-6’), 111.1 (Ar-C-H-5), 111.0 (Ar-C-H-5’), 109.7 (Ar-C-H-2), 
105.8 (Ar-C-H-2’), 56.1 (Ar-OCH3), 55.96 (Ar-OCH3), 55.94 (Ar-OCH3), 55.8 (Ar-OCH3). MS: m/z 
(EI+) 344 (M+, 13 %), 191 (100 %) HRMS (EI+): Calcd for C19H20O6 = 344.1260 (M
+), found 
344.1256. 
4-(3,4-Dimethoxyphenyl)-1,4-dihydro-3H-isochromen-3-one 8a and 2,2’-(dimethylenebiphenyl-
2,2’-diyl) [di(3,4-dimethoxyphenyl)]diacetate 9a 
Compounds 8a (white film, 20 mg, 29 %) and 9a (white film, 31 mg, 30%) were prepared from 7a 
(100 mg, 0.24 mmol), in the presence of (Ph3P)2PdCl2 (44 mg, 0.063 mmol), NaOAc (60 mg, 0.73 
mmol) and DMA (25 mL) according to the general arylation method described above.  
8a: 1H NMR: δ 7.38 (d, 1H, J = 8.4 Hz, Ar-H-5), 7.37 (t, 1H, J = 8.4 Hz, Ar-H-7), 7.29 (d, 1H, J = 8.4 
Hz, Ar-H-8), 7.15 (t, 1H, J = 8.4 Hz, Ar-H-6), 6.81 (d, 1H, J = 2.1 Ar-H-2’), 6.78 (d, 1H, J = 8.2 Hz, 
Ar-H-5’), 6.53 (dd, 1H, J = 8.2, 2.1 Hz, Ar-H-6’), 5.23 (ABq, 2H, J = 16.5 Hz, Ar-CH2-O), 4.95 (Ar-
CH-CO), 3.85 (s, 3H, OCH3-4’), 3.82 (s, 3H, OCH3-3’). 
13C NMR: δ 171.6 (C=O), 149.6 (Ar-C-OCH3-
3’), 149.0 (Ar-C-OCH3-4’), 134.4 (Ar-C-5a), 132.2 (Ar-C-8a), 129.2 (Ar-C-H-5), 128.2 (Ar-C-H-6), 
128.0 (Ar-C-H-7), 126.7 (Ar-C-1’), 125.0 (Ar-C-H-8), 120.5 (Ar-C-H-6’), 111.7 (Ar-C-H-2’), 111.3 
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(Ar-C-H-5’), 69.7 (Ar-CH2-O), 56.1 (2 x Ar-OCH3-3, 4), 51.5 (Ar-CH-CO). MS: m/z (EI
+) 284 (M+, 73 
%), 209 (100 %), HRMS (EI+): Calcd for C17H16O4 = 284.1048 (M
+), found 284.1057. 
9a: 1H NMR: δ 7.37 (dd, 2H, J = 7.5, 1.5 Hz, Ar-H-3’), 7.33 (dt, 2H, J = 7.5, 1.5 Hz, Ar-H-5’), 7.28 
(dt, 2H, J = 7.5, 1.5 Hz, Ar-H-4’), 7.11 (dd, 2H, J = 7.5, 1.0 Hz, Ar-H-6’), 6.78 (d, 2H, J = 9.0 Hz, Ar-
H-5), 6.74 (dd, 2H, J = 9.0, 1.5 Hz, Ar-H-6), 6.73 (bs, 2H, Ar-H-2), 4.83 (ABq, 4H, J = 12.5, Hz Ar-
CH2-O), 3.85 (s, 6H, OCH3-4), 3.81 (s, 6H, OCH3-3), 3.48 (s, 4H, Ar-CH2-CO). 
13C NMR: δ 171.2 
(C=O), 148.8 (Ar-C-OCH3-3), 148.1 (Ar-C-OCH3-4), 139.6 (Ar-C-H-3’), 133.7 (Ar-C-1’), 129.9 (Ar-
C-2’), 128.9 (Ar-C-H-3’), 127.9 (2 x Ar-C-H-4’, 5’), 126.2 (Ar-C-1), 121.4 (Ar-C-H-6), 112.3 (Ar-C-
H-2), 111.1 (Ar-C-H-5), 64.5 (Ar-CH2-O), 55.8 (Ar-OCH3-4), 55.7 (Ar-OCH3-3), 40.7 (Ar-CH2-CO).  




4-(3,4-Dimethoxyphenyl)-6,7-dimethoxy-1,4-dihydro-3H-isochromen-3-one 8b and 2,2’-
[dimethylene(4,4’,5,5’-tetramethoxybiphenyl-2,2’-diyl](di(3,4-dimethoxyphenyl))diacetate 9b 
Compounds 8b (yellow film, 21 mg, 29 %) and 9b (orange film, 39 mg, 46%) were prepared from 7b 
(115 mg, 0.24 mmol), in the presence of (Ph3P)2PdCl2 (44 mg, 0.063 mmol), NaOAc (60 mg, 0.73 
mmol) and DMA (25 mL) according to the general arylation method described above.  
8b: see following procedure for spectral data of this compound. 
9b: 1H NMR: δ 6.84 (s, 2H, Ar-H-6’), 6.78 (d, 2H, J = 9.0 Hz, Ar-H-5), 6.76 (d, 2H, J = 9.0 Hz, Ar-H-
6), 6.75 (bs, 2H, Ar-H-2), 6.69 (s, 2H, Ar-H-3’), 4.81 (ABq, 4H, J = 12.0 Hz, Ar-CH2-O), 3.85 (s, 6H, 
OCH3-5’), 3.84 (s, 6H, OCH3-4’), 3.81 (s, 6H, OCH3-3), 3.80 (s, 6H OCH3-4), 3.51 (s, 4H Ar-CH2-
CO). 13C NMR: δ 171.3 (C=O), 148.9 (Ar-C-OCH3-4’), 148.4 (2x Ar-C-OCH3-3, 4), 148.3 (Ar-C-
OCH3-3’), 132.3 (Ar-C-1’), 126.3 (Ar-C-2’), 126.2 (Ar-C-1), 121.3 (Ar-C-H-6), 113.1 (Ar-C-H-3), 
112.3 (Ar-C-H-2), 111.9 (Ar-C-H-6), 111.1 (Ar-C-H-5), 64.4 (Ar-CH2-O), 56.0 (Ar-OCH3-3), 55.9 
(Ar-OCH3-4), 55.8 (Ar-OCH3-4’), 55.7 (Ar-OCH3-3’), 40.8 (Ar-CH2-CO). MS: m/z (EI
+) 690 (M+, 11 
%), 368 (100 %), HRMS (EI+): Calcd for C38H42O12 = 690.2676 (M
+), found 690.2679. 
 
4-(3,4-Dimethoxyphenyl)-6,7-dimethoxy-1,4-dihydro-3H-isochromen-3-one 8b 
The title compound was also prepared in 21 % yield (yellow film, 15 mg) from 3,4-dimethoxybenzyl 
(2-iodo-4,5-dimethophenyl)acetate (115 mg, 0.24 mmol), in the presence of (Ph3P)2PdCl2 (44 mg, 
0.063 mmol), NaOAc (60 mg, 0.73 mmol) and DMA (25 mL) according to the general arylation 
method described above. 1H NMR: δ 6.84 (d, 1H, J = 2.0 Ar-H-2’), 6.77 (s, 1H, Ar-H-5), 6.78 (d, 1H, J 
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= 8.7 Hz, Ar-H-5’), 6.65 (s, 1H, Ar-H-8), 6.51 (dd, 1H, J = 8.7, 2.0 Hz, Ar-H-6’), 5.17 (ABq, 2H, J = 
13.5 Hz, Ar-CH2-O), 4.89 (Ar-CH-CO), 3.92 (s, 3H, OCH3-6), 3.85 (s, 3H, OCH3-7), 3.84 (s, 3H, 
OCH3-3’), 3.83 (s, 3H, OCH3-4’). 
13C NMR: δ 171.5 (C=O), 149.8 (Ar-C-OCH3-3), 149.6 (Ar-C-
OCH3-4’), 149.0 (Ar-C-OCH3-4), 148.8 (Ar-C-OCH3-5’), 127.0 (Ar-C-5a), 126.2 (Ar-C-1’), 124.3 (Ar-
C-8a), 120.2 (Ar-C-H-6’), 111.5 (Ar-C-H-2’), 111.3 (Ar-C-H-5’), 111.2 (Ar-C-H-8), 108.1 (Ar-C-H-
5), 69.6 (Ar-CH2-O), 56.4 (Ar-OCH3), 56.3 (Ar-OCH3), 56.2 (Ar-OCH3), 56.1 (Ar-OCH3), 50.9 (Ar-
CH-CO). MS: m/z (EI+) 344 (M+, 46 %), 269 (100 %), HRMS (CI+): Calcd for C19H21O6 = 345.1338 
(M+H+), found 345.1327. 
 
Di-(3,4-dimethoxybenzyl) 2,3-diphenylsuccinate 11 and di-(3,4-dimethoxybenzyl) 2,2’-biphenyl-
2,2’-diylacetate 12 
Compound 11 was prepared in 27 % yield (clear film, 19 mg) from 10a (100 mg, 0.24 mmol), in the 
presence of (Ph3P)2PdCl2 (65 mg, 0.093 mmol), NaOAc (60 mg, 0.73 mmol) and DMA (25 mL) 
according to the general arylation method described above, and with HPLC separation of 12 (clear 
film, 4 mg, 7 %) from the reaction mixture. The major and minor diastereomers could not be separated 
by HPLC and are reported together. The diastereomeric ratio was major: minor = 1.8:1. NMR signals 
for the minor diastereomer are shown in brackets. 
11: 1H NMR: δ 7.47 (dd, 2H, J = 7.5, 2.1 Hz, Ar-H-4), 7.13 (t, 4H, J = 7.5 Ar-H-3,5), 7.03 (dd, 4H, Ar-
H-2,6), 6.73 (d, 2H, J = 7.8 Hz, Ar-H-5’), 6.59 (dd, 2H, J = 7.8, 2.1 Hz, Ar-H-6’), 6.48 (d, 2H, J = 2.1 
Hz, Ar-H-2’), 5.04 (4.76) (ABq, 4H, J = 12.3 Hz, (ABq, 4H, J = 12.0 Hz), Ar-CH2-O), 4.30 (4.43) (s, 
2H, Ar-CH-CO), 3.85 (3.85) (s, 3H, OCH3-3’), 3.74 (3.69) (s, 3H, OCH3-4’). 
13C NMR: δ 172.8 
(171.4) (C=O), 148.9 (Ar-C-OCH3-3’), 148.8 (Ar-C-OCH3-4’), 135.5 (136.1) (Ar-C-H-2’), 128.5 
(128.6) (Ar-C-H-4), 128.3 (128.2) (Ar-C-H-3,5), 128.4 (Ar-C-1), 128.0 (127.9) (Ar-C-1’), 127.4 
(127.8) (Ar-C-H-2,6), 120.8 (120.5) (Ar-C-H-6’), 110.9 (111.2) (Ar-C-H-2’), 110.7 (110.9) (Ar-C-H-
5’), 66.6 (Ar-CH2-O), 55.8 (Ar-OCH3), 55.7 (55.6) (Ar-OCH3), 54.8 (54.9) (Ar-CH-CO). MS: m/z 
(EI+) 570 (M+, 10 %), 151 (100 %), HRMS (EI+): Calcd for C34H34O8 = 570.2253 (M
+), found 
570.2231. 
12: 1H NMR: δ 7.30-7.26 (m, 4H, Ar-H-5,6), 7.22-7.16 (m, 4H, Ar-H-3,4), 7.07 (d, 2H, J = 7.2 Hz, Ar-
H-5), 6.78 (d, 2H, J = 1.2 Hz, Ar-H-2’),  6.72 (dd, 2H, J = 7.2, 1.2 Hz, Ar-H-6’), 4.91 (s, 4H Ar-CH2-
O), 3.85 (s, 6H, OCH3-3’), 3.80 (s, 6H OCH3-4’), 3.36 (ABq, 4H, J = 16.0 Hz, Ar-CH2-CO).  
13C NMR: δ 171.4 (C=O), 149.0 (Ar-C-OCH3-4’), 148.9 (Ar-C-OCH3-3’), 140.6 (Ar-C-H-3), 132.4 
(Ar-C-1’), 130.2 (Ar-C-H-5), 130.1 (Ar-C-H-4), 128.5 (Ar-C-1), 127.7 (Ar-C-H-6), 126.9 (Ar-C-2’), 
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121.1 (Ar-C-H-6’), 111.6 (Ar-C-H-2’), 110.8 (Ar-C-H-5’), 66.9 (Ar-CH2-O), 55.9 (Ar-OCH3-4’), 55.8 
(Ar-OCH3-3’), 38.7 (Ar-CH2-CO).  MS: m/z (EI
+) 570 (M+, 5 %), 151 (100 %), HRMS (EI+): Calcd for 
C34H34O8 = 570.2253 (M
+), found 570.2239. 
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